Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
Crossref DOI link: https://doi.org/10.1007/s00417-017-3647-4
Published Online: 2017-05-19
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Lanzetta, Paolo
Loewenstein, Anat
License valid from 2017-05-19